American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Sumitomo Mitsui Financial Group (NYSE:SMFG) Reaches New 52-Week High at $12.50

Sumitomo Mitsui Financial Group (NYSE:SMFG) Reaches New 52-Week High at $12.50

Sumitomo Mitsui Financial Group, Inc. (NYSE:SMFG – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Friday . The company traded as high as $12.50 and last traded at $12.50, with a volume... More of this article »
Image about Safe Bulkers (NYSE:SB) Sets New 12-Month High at $5.64

Safe Bulkers (NYSE:SB) Sets New 12-Month High at $5.64

Safe Bulkers, Inc. (NYSE:SB – Get Free Report)’s share price hit a new 52-week high during trading on Friday . The company traded as high as $5.64 and last traded at $5.64, with a volume of 82430 shares changing hands.... More of this article »
Image about Royal Gold (NASDAQ:RGLD) Hits New 12-Month High at $132.71

Royal Gold (NASDAQ:RGLD) Hits New 12-Month High at $132.71

Royal Gold, Inc. (NASDAQ:RGLD – Get Free Report) (TSE:RGL) shares hit a new 52-week high on Friday . The company traded as high as $132.71 and last traded at $132.11, with a volume of 53350 shares changing hands. The stock had... More of this article »
Image about BRF (NYSE:BRFS) Hits New 12-Month High After Analyst Upgrade

BRF (NYSE:BRFS) Hits New 12-Month High After Analyst Upgrade

Brf S.A. (NYSE:BRFS – Get Free Report) shares hit a new 52-week high during trading on Friday after Barclays raised their price target on the stock from $4.00 to $4.50. Barclays currently has an overweight rating on the stock.... More of this article »
Image about Interactive Brokers Group (NASDAQ:IBKR) Sets New 52-Week High at $122.94

Interactive Brokers Group (NASDAQ:IBKR) Sets New 52-Week High at $122.94

Interactive Brokers Group, Inc. (NASDAQ:IBKR – Get Free Report) hit a new 52-week high on Friday . The company traded as high as $122.94 and last traded at $122.68, with a volume of 44609 shares. The stock had previously closed... More of this article »
Image about Rogers Sugar Inc. (TSE:RSI) Receives Consensus Rating of “Hold” from Analysts

Rogers Sugar Inc. (TSE:RSI) Receives Consensus Rating of “Hold” from Analysts

Shares of Rogers Sugar Inc. (TSE:RSI – Get Free Report) have received a consensus recommendation of “Hold” from the four brokerages that are presently covering the company, Marketbeat.com reports. Three investment... More of this article »
Image about Head-To-Head Review: Debenhams (OTCMKTS:DBHSY) and THK (OTCMKTS:THKLY)

Head-To-Head Review: Debenhams (OTCMKTS:DBHSY) and THK (OTCMKTS:THKLY)

Debenhams (OTCMKTS:DBHSY – Get Free Report) and THK (OTCMKTS:THKLY – Get Free Report) are both retail/wholesale companies, but which is the superior investment? We will compare the two businesses based on the strength of... More of this article »
Image about Ultrapar Participações S.A. (NYSE:UGP) Given Consensus Recommendation of “Reduce” by Brokerages

Ultrapar Participações S.A. (NYSE:UGP) Given Consensus Recommendation of “Reduce” by Brokerages

Shares of Ultrapar Participações S.A. (NYSE:UGP – Get Free Report) have been assigned a consensus recommendation of “Reduce” from the five ratings firms that are covering the stock, Marketbeat.com reports. One... More of this article »
Image about Critical Review: Avis Budget Group (NASDAQ:CAR) & Zoomcar (NASDAQ:ZCAR)

Critical Review: Avis Budget Group (NASDAQ:CAR) & Zoomcar (NASDAQ:ZCAR)

Zoomcar (NASDAQ:ZCAR – Get Free Report) and Avis Budget Group (NASDAQ:CAR – Get Free Report) are both auto/tires/trucks companies, but which is the superior business? We will contrast the two businesses based on the strength... More of this article »
Image about Thomson Reuters Co. (TSE:TRI) Given Average Rating of “Hold” by Brokerages

Thomson Reuters Co. (TSE:TRI) Given Average Rating of “Hold” by Brokerages

Thomson Reuters Co. (TSE:TRI – Get Free Report) (NYSE:TRI) has been given a consensus rating of “Hold” by the seven analysts that are covering the company, Marketbeat.com reports. Five investment analysts have rated... More of this article »
Image about Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Rating of “Moderate Buy” from Analysts

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight research firms that are covering the company, MarketBeat reports. One... More of this article »
Image about Reviewing Alibaba Health Information Technology (OTC:ALBHF) and Walgreens Boots Alliance (NASDAQ:WBA)

Reviewing Alibaba Health Information Technology (OTC:ALBHF) and Walgreens Boots Alliance (NASDAQ:WBA)

Alibaba Health Information Technology (OTC:ALBHF – Get Free Report) and Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies... More of this article »
Image about Vivid Seats Inc. (NASDAQ:SEAT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Vivid Seats Inc. (NASDAQ:SEAT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Vivid Seats Inc. (NASDAQ:SEAT – Get Free Report) has earned an average rating of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat reports. Three equities research analysts have rated... More of this article »
Image about SmartFinancial, Inc. (NASDAQ:SMBK) Given Consensus Recommendation of “Moderate Buy” by Analysts

SmartFinancial, Inc. (NASDAQ:SMBK) Given Consensus Recommendation of “Moderate Buy” by Analysts

SmartFinancial, Inc. (NASDAQ:SMBK – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the five analysts that are presently covering the stock, MarketBeat Ratings reports. Two investment... More of this article »
Image about Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Average Rating of “Buy” from Analysts

Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Average Rating of “Buy” from Analysts

Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have been given a consensus rating of “Buy” by the eight brokerages that are covering the company, MarketBeat reports. Seven investment analysts have... More of this article »